• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue3

DIAGNOSTIC SENSITIVITY OF BIOMARKERS IN ASSESSING THE OCCURRENCE AND PROGRESSION OF DIABETIC NEPHROPATHY

    Mr.Kondapi Kishore Dr Santhi Silambanan Dr Swathy Moorthy

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 1554-1571

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background
Diabetic nephropathy is a major end stage kidney disease and its timely diagnosis helps in combating the morbidity and mortality associated with it, thereby improving the quality of the patients suffering from the condition. Though identification of microalbuminuria has long been used to diagnose the nephropathy among diabetics, there has always a need for sensitive and specific biomarker that could predict the susceptibility of the diabetic patients to develop nephropathy much ahead of the onset of microalbuminuria.
Methods
A prospective study was conducted among 125 diabetic patients at various levels of nephropathy like the normoalbuminuric, microalbuminuric and macroalbuminuric patients and 45 healthy controls based on the Joint Committee of Diabetic Nephropathy Classification. A detailed history, clinical characteristics, duration of illness and other baseline investigations along with urinary podocin, urine nephrin, serum carboxy-methyl lysine levels, glycated albumin, glycaemic control, lipid profile were analyzed among the various nephropathy stages and compared with the controls.
Keywords:
    Urinary Podocin Nephrin n-Carboxy methyl lysine Glycated Albumin seem to have very good to excellent diagnostic value in accordance to microalbumin and HbA1c followed by HOMA-IR in the diagnosis of onset and progression of diabetic nephropathy
  • PDF (500 K)
  • XML
(2021). DIAGNOSTIC SENSITIVITY OF BIOMARKERS IN ASSESSING THE OCCURRENCE AND PROGRESSION OF DIABETIC NEPHROPATHY. European Journal of Molecular & Clinical Medicine, 8(3), 1554-1571.
Mr.Kondapi Kishore; Dr Santhi Silambanan; Dr Swathy Moorthy. "DIAGNOSTIC SENSITIVITY OF BIOMARKERS IN ASSESSING THE OCCURRENCE AND PROGRESSION OF DIABETIC NEPHROPATHY". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 1554-1571.
(2021). 'DIAGNOSTIC SENSITIVITY OF BIOMARKERS IN ASSESSING THE OCCURRENCE AND PROGRESSION OF DIABETIC NEPHROPATHY', European Journal of Molecular & Clinical Medicine, 8(3), pp. 1554-1571.
DIAGNOSTIC SENSITIVITY OF BIOMARKERS IN ASSESSING THE OCCURRENCE AND PROGRESSION OF DIABETIC NEPHROPATHY. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 1554-1571.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 204
  • PDF Download: 458
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus